| 10th week of 2018 patent applcation highlights part 8 |
| Patent application number | Title | Published |
|---|
| 20180064726 | Deuterium-Substituted Oxazepin Compounds | 2018-03-08 |
| 20180064727 | V1A ANTAGONISTS TO TREAT PHASE SHIFT SLEEP DISORDERS | 2018-03-08 |
| 20180064728 | TREATMENT OF SYMPTOMS RELATED TO NEURODEGENERATIVE DISORDERS THROUGH PHARMACOLOGICAL DERMAL ACTIVATION OF CRANIAL NERVES | 2018-03-08 |
| 20180064729 | Treatment of Pulmonary Disease | 2018-03-08 |
| 20180064730 | Cardiac glycosides to reduce pulmonary exacerbations and other adverse events in cystic fibrosis and other related disorders | 2018-03-08 |
| 20180064731 | SMALL MOLECULE THERAPEUTIC COMPOUNDS THAT REDUCE THE INCIDENCE OF INTRACEREBRAL HEMORRHAGE AND BRAIN MICROHEMORRHAGES | 2018-03-08 |
| 20180064732 | COMPOSITIONS AND METHODS FOR SUPPRESSING OR REDUCING SYSTEMIC IMMUNE RESPONSE IN A SUBJECT | 2018-03-08 |
| 20180064733 | USE OF BISPHOSPHONATES AS HIV/AIDS ADJUNCTIVE TREATMENT | 2018-03-08 |
| 20180064734 | NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME | 2018-03-08 |
| 20180064735 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN SYNDROME | 2018-03-08 |
| 20180064736 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN SYNDROME | 2018-03-08 |
| 20180064737 | ACYCLIC NUCLEOSIDE PHOSPHONATE DIESTERS | 2018-03-08 |
| 20180064738 | METHOD OF TREATING INFECTIONS USING SILOXANE DERIVATIVES | 2018-03-08 |
| 20180064739 | NUTRITIONAL COMPOSITION WITH HUMAN MILK OLIGOSACCHARIDES AND USES THEREOF | 2018-03-08 |
| 20180064740 | USE OF GINSENOSIDE M1 FOR PREVENTING OR TREATING GOUT | 2018-03-08 |
| 20180064741 | USE OF GINSENOSIDE M1 FOR PREVENTING OR TREATING SILICOSIS | 2018-03-08 |
| 20180064742 | PET IMAGING TRACER FOR IMAGING PROSTATE CANCER | 2018-03-08 |
| 20180064743 | NOVEL AMINOGLYCOSIDES AND USES THEREOF IN THE TREATMENT OF GENETIC DISORDERS | 2018-03-08 |
| 20180064744 | NUCLEOSIDE AGENTS FOR THE REDUCTION OF THE DELETERIOUS ACTIVITY OF EXTENDED NUCLEOTIDE REPEAT CONTAINING GENES | 2018-03-08 |
| 20180064745 | COMPOSITIONS AND METHODS FOR ACTIVATING "STIMULATOR OF INTERFERON GENE" - DEPENDENT SIGNALLING | 2018-03-08 |
| 20180064746 | ASSAY FOR TELOMERE LENGTH REGULATORS | 2018-03-08 |
| 20180064747 | DNA-FUNCTIONALIZED SCAFFOLDS FOR DRUG CAPTURE APPLICATIONS | 2018-03-08 |
| 20180064748 | METHODS OF TREATING MOTOR NEURON DISEASES | 2018-03-08 |
| 20180064749 | CONJUGATION OF LIPOPHILIC ALBUMIN-BINDING MOIETY TO RNA FOR IMPROVED CARRIER-FREE IN VIVO PHARMACOKINETICS AND GENE SILENCING | 2018-03-08 |
| 20180064750 | Methods of Treating Osteoarthritis | 2018-03-08 |
| 20180064751 | COMPOSITIONS AND METHODS FOR TREATING HYPERKALEMIA | 2018-03-08 |
| 20180064752 | ANIONICALLY MODIFIED POLYALLYLAMINE DERIVATIVE, USE OF ANIONICALLY MODIFIED POLYALLYLAMINE DERIVATIVE AS MEDICINE, PARTICULARLY FOR PROPYLAXIS AND TREATMENT OF INFECTIONS OF RESPIRATORY TRACT CAUSED BY HUMAN METAPNEUMOVIRUS (HMPV), HUMAN RHINOVIRUSES (HRV), AND INFECTION BY INFLUENZA VIRUS TYPE A (IAV) AND PHARMACEUTICAL COMPOSITION COMPRISING THE ANIONICALLY MODIFIED POLYALLYLAMINE DERIVATIVE | 2018-03-08 |
| 20180064753 | PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING TRYPSINOGEN AND/OR CHYMOTRYPSINOGEN AND AN ACTIVE AGENT SELECTED FROM A SELENIUM COMPOUND, A VANILLOID COMPOUND AND A CYTOPLASMIC GLYCOLYSIS REDUCTION AGENT | 2018-03-08 |
| 20180064754 | MAGNESIUM-CONTAINING PRODUCTS AND USES THEREOF | 2018-03-08 |
| 20180064755 | COMPOSITIONS AND METHODS FOR TREATING DRUG ADDICTION | 2018-03-08 |
| 20180064756 | TREATMENT WATER OF LIFESTYLE-RELATED DISEASES AND METHOD OF TREATING THE LIFESTYLE-RELATED DISEASES | 2018-03-08 |
| 20180064757 | FORMULATION FOR PREVENTING OR TREATING DENTIN-ASSOCIATED SYMPTOMS OR DISEASES, AND METHOD USING THE SAME | 2018-03-08 |
| 20180064758 | CHIMERIC ANTIGEN RECEPTOR | 2018-03-08 |
| 20180064759 | MULTIPOTENT STEM CELLS AND USES THEREOF | 2018-03-08 |
| 20180064760 | Methods for Treating or Preventing Graft Versus Host Disease | 2018-03-08 |
| 20180064761 | MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA | 2018-03-08 |
| 20180064762 | ABCB5(+) STEM CELLS FOR TREATING OCULAR DISEASE | 2018-03-08 |
| 20180064763 | CRYOPRESERVATION, HIBERNATION AND ROOM TEMPERATURE STORAGE OF ENCAPSULATED PANCREATIC ENDODERM CELL AGGREGATES | 2018-03-08 |
| 20180064764 | COMPOSITIONS OF MORSELIZED UMBILICAL CORD AND/OR AMNIOTIC MEMBRANE AND METHODS OF USE THEREOF | 2018-03-08 |
| 20180064765 | LISTERIA-BASED IMMUNOGENIC COMPOSITIONS FOR ELICITING ANTI-TUMOR RESPONSES | 2018-03-08 |
| 20180064766 | Composition for preventing or treating of colitis disease comprising Lactobacillus sakei K040706 as an active ingredient | 2018-03-08 |
| 20180064767 | Control of Cellular Redox Levels | 2018-03-08 |
| 20180064768 | Control of Cellular Redox Levels | 2018-03-08 |
| 20180064769 | Control of Cellular Redox Levels | 2018-03-08 |
| 20180064770 | Composite with the Function of Regulating Blood Glucose | 2018-03-08 |
| 20180064771 | METHODS FOR PROTECTING SKIN AND/OR PROMOTING WOUND HEALING | 2018-03-08 |
| 20180064772 | MEDICATION DISPENSING SYSTEM | 2018-03-08 |
| 20180064773 | COMPOSITIONS OF MEDICINAL PLANTS FOR REDUCING THE EFFECTS OF AGING, PREVENTION AND TREATMENT OF AGE-RELATED NEURODEGENERATIVE DISEASES, AND TREATMENT OF ANXIETY AND SLEEP DISORDERS | 2018-03-08 |
| 20180064774 | COMPOSITIONS FOR USE IN THE TREATMENT OF TUMORS RESISTANT TO CHEMOTHERAPY | 2018-03-08 |
| 20180064775 | ANTI-PATHOGENIC COMPOSITIONS | 2018-03-08 |
| 20180064776 | COMPOSITION AND FORMULATION BASED ON PTERODON PUBESCENS BENTH. AND CORDIA VERBENACEA DC EXTRACTS/ESSENTIAL OILS, AND USES THEREOF | 2018-03-08 |
| 20180064777 | Skin Solution with Solubilized Bakuchiol | 2018-03-08 |
| 20180064778 | Compositions and Methods for Improvement of Mood | 2018-03-08 |
| 20180064779 | Compositions and Methods for Managing or Improving Bone Disorders, Joint Disorders, Cartilage Disorders, or a Combination Thereof | 2018-03-08 |
| 20180064780 | SHEAR CONTROLLED RELEASE FOR STENOTIC LESIONS AND THROMBOLYTIC THERAPIES | 2018-03-08 |
| 20180064781 | Sincalide Formulations | 2018-03-08 |
| 20180064782 | IMPLANTABLE MESHES FOR CONTROLLING THE MOVEMENT OF FLUIDS | 2018-03-08 |
| 20180064783 | PRODUCTS AND METHODS USING SOY PEPTIDES TO LOWER TOTAL AND LDL CHOLESTEROL LEVELS | 2018-03-08 |
| 20180064784 | LIQUID NUTRITIONAL FORMULA FOR TYROSINEMIA PATIENTS | 2018-03-08 |
| 20180064785 | METHOD OF AMELIORATING OR PREVENTING THE WORSENING OR THE PROGRESSION OF SYMPTOMS OF BPH | 2018-03-08 |
| 20180064786 | Compositions for Treating Pathological Calcification Conditions, and Methods Using Same | 2018-03-08 |
| 20180064787 | COMPOSITIONS AND METHODS FOR ADJOINING TYPE I AND TYPE II EXTRACELLULAR DOMAINS AS HETEROLOGOUS CHIMERIC PROTEINS | 2018-03-08 |
| 20180064788 | TREATING NEURODEGENERATIVE DISEASES WITH PROGRANULIN | 2018-03-08 |
| 20180064789 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PANCREATIC CANCER | 2018-03-08 |
| 20180064790 | Composition for Treatment or Prevention of Infectious Inflammatory Diseases, or Composition for Immune Enhancement, Comprising Tryptophanyl-tRNA Synthetase as an Active Ingredient | 2018-03-08 |
| 20180064791 | IMMUNOGENIC COMPOSITIONS AND VACCINES FOR PREVENTING OR TREATING FILARIAL DISEASE | 2018-03-08 |
| 20180064792 | IMMUNIZING PEPTIDE, METHOD FOR PRODUCING IMMUNIZING PEPTIDE, PHARMACEUTICAL COMPOSITION FOR IMMUNE DISEASE CONTAINING SAME, AND METHOD FOR TREATING IMMUNE DISEASE | 2018-03-08 |
| 20180064793 | METHOD FOR TREATING CANCER | 2018-03-08 |
| 20180064794 | NOVEL MSLN TARGETING DNA VACCINE FOR CANCER IMMUNOTHERAPY | 2018-03-08 |
| 20180064795 | HLA-A* 1101-RESTRICTED WT1 PEPTIDE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | 2018-03-08 |
| 20180064796 | Novel peptides and combination of peptides and scaffolds for use in immunotherapy against Renal Cell Carcinoma (RCC) and other cancers | 2018-03-08 |
| 20180064797 | METHODS AND MATERIALS FOR GENERATING CD8+ T CELLS HAVING THE ABILITY TO RECOGNIZE CANCER CELLS EXPRESSING A HER2/NEU POLYPEPTIDE | 2018-03-08 |
| 20180064798 | VACCINES FOR PREVENTION AND TREATMENT OF TUBERCULOSIS | 2018-03-08 |
| 20180064799 | POLYPEPTIDES AND IMMUNIZING COMPOSITIONS CONTAINING BACILLUS POLYPEPTIDES AND METHODS OF USE | 2018-03-08 |
| 20180064800 | MUTANT STAPHYLOCOCCAL ANTIGENS | 2018-03-08 |
| 20180064801 | VACCINES FOR NEISSERIA GONORRHOEAE | 2018-03-08 |
| 20180064802 | Immunogenic Human Rhinovirus (HRV) Composition | 2018-03-08 |
| 20180064803 | METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST HUMAN IMMUNODEFICIENCY VIRUS INFECTION IN SUBJECTS UNDERGOING ANTIRETROVIRAL TREATMENT | 2018-03-08 |
| 20180064804 | PORCINE EPIDEMIC DIARRHEA VIRUS STRAINS AND IMMUNOGENIC COMPOSITIONS THEREFROM | 2018-03-08 |
| 20180064805 | Method of Vaccination Comprising a Histone Deacetylase Inhibitor | 2018-03-08 |
| 20180064806 | IMMUNOGENIC COMPOSITION | 2018-03-08 |
| 20180064807 | NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS | 2018-03-08 |
| 20180064808 | COMBINATION THERAPY OF BISPECIFIC ANTIBODIES SPECIFIC FOR FAP AND DR5 AND CHEMOTHERAPEUTIC AGENTS | 2018-03-08 |
| 20180064809 | ANTI-DC-HIL ANTIBODIES FOR CANCER DIAGNOSIS, PROGNOSIS AND THERAPY | 2018-03-08 |
| 20180064810 | USE OF RANK/RANKL ANTAGONISTS FOR TREATING NEUROMUSCULAR DISORDERS, GENETIC MYOPATHIES AND/OR NON GENETIC MYOPATHIES AND/OR FOR REGULATING SKELETAL AND CARDIAC MUSCLE DISUSE, DISEASES AND AGING | 2018-03-08 |
| 20180064811 | PHARMACEUTICAL COMBINATIONS COMPRISING CD33 ANTIBODIES AND DE-METHYLATING AGENTS | 2018-03-08 |
| 20180064812 | MICROCAPSULE HAVING A MICROCAPSULE SHELL MATERIAL THAT IS RUPTURABLE VIA A RETRO-DIMERIZATION REACTION | 2018-03-08 |
| 20180064813 | Oral Composition for Delivery of Drugs and Other Substances | 2018-03-08 |
| 20180064814 | Naltrexone Long Acting Formulations and Methods of Use | 2018-03-08 |
| 20180064815 | PHOTOCROSSLINKED BIODEGRADABLE HYDROGEL | 2018-03-08 |
| 20180064816 | CROSSLINKED HYALURONIC ACID COMPOSITIONS | 2018-03-08 |
| 20180064817 | Tamper Resistant Pharmaceutical Composition | 2018-03-08 |
| 20180064818 | PHARMACEUTICAL COMPOSITION COMPRISING POLYPEPTIDE | 2018-03-08 |
| 20180064819 | Targeting Ligands | 2018-03-08 |
| 20180064820 | Benzoic Acid, Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates of Hydromorphone, Prodrugs, Methods of Making and Use Thereof | 2018-03-08 |
| 20180064821 | SITE SPECIFIC CURCUMIN-POLYMER MOLECULAR COMPLEXES AND METHODS OF TREATING COLON DISEASES AND INFLAMMATION | 2018-03-08 |
| 20180064822 | METHOD INVOLVING 1-BENZOTRIAZOLYL CARBONATE ESTERS OF POLY(ETHYLENE GLYCOL) | 2018-03-08 |
| 20180064823 | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS | 2018-03-08 |
| 20180064824 | CONJUGATE BASED SYSTEMS FOR CONTROLLED DRUG DELIVERY | 2018-03-08 |
| 20180064825 | ANTI-PD-L1 IMMUNOTOXIN FOR USE IN THERAPY | 2018-03-08 |
